Patents and Patent Applications from Emory University


Match Document Document Title
6107281 Compounds and their combinations for the treatment of influenza infection  
Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or N-acetyl-L-cysteine, with or without antioxidants, is suitable for the treatment of influenza virus...
6093699 Method for gene therapy involving suppression of an immune response  
A method for specifically suppressing the capacity of a mammal receiving gene therapy to mount an immune response to a given expressed gene of the deficient gene in question, which response is...
6086525 Magnetic nerve stimulator for exciting peripheral nerves  
A magnetic nerve stimulator system is comprised of a core constructed from a material having a high field saturation with a coil winding. A thyrister capacitive discharge circuit pulses the device....
6083167 Systems and methods for providing radiation therapy and catheter guides  
A system and method for the prevention of restenosis uses a source of radiation to treat the blood vessel. An intra-vascular ultrasound system acquires precise two-dimensional images of a treatment...
6077662 Virus-like particles, methods and immunogenic compositions  
The present disclosure provides retrovirus-like particles which comprise retrovirus env proteins, immunogenic compositions comprising retrovirus-like particles, methods for the production of...
6071922 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides  
A method and composition for the treatment of HIV infection, HBV infection, or abnormal cellular proliferation in humans and other host animals is disclosed that includes the administration of an...
6071532 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof  
The present invention provides glycophospholipid and peptide-phospholipid conjugates comprising a phospholipid moiety and a saccharide or peptide moiety joined by an ether linkage comprising a...
6069252 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers  
A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of...
6066628 Non-iron metalloporphyrins and methods of use  
The present disclosure provides novel non-iron metalloporphyrins, especially those porphyrin complexes containing gallium or indium as the metal ion, and antibacterial compositions comprising...
6064906 Method, system and apparatus for determining prognosis in atrial fibrillation  
A system, apparatus and method for determining prognosis in atrial fibrillation non-invasively detects electrical activity of the heart with external electrodes, such as with ECG leads. The...
6060643 Mouse model with human immune system  
The present invention provides a non-human genetically immunodeficient mammal the peripheral blood of which contains a non-lethal percent of T-cells of human origin which is at least 20% as well as...
6042538 Device for endoscopic vessel harvesting  
A endoscopic device provides improvements in the endoscopic working space by the use of a semi-tubular hood with an arched top wall and self-supporting walls that allow simultaneous manipulations...
6037332 Method of urinary bladder instillation  
Growth of transition cell carcinoma cells is found to be inhibited by dextran sulfate. Intravesicular instillation of a dextran sulfate solution prevents growth of bladder carcinoma cells. Dextran...
6024740 Circumferential ablation device assembly  
This invention is a circumferential ablation device assembly which is adapted to forming a circumferential conduction block in a pulmonary vein. The assembly includes a circumferential ablation...
6019974 SPE-4 peptides  
This application discloses SPE-4 related peptides, peptide-carrier protein conjugates and fusion proteins, immunogenic compositions, antibodies and methods for characterizing the SPE-4 related...
6013858 Mouse lacking heart-muscle adenine nucleotide translocator protein and methods  
Provided are transgenic mice genetically engineered for a deficiency of the heart-skeletal muscle isoform of the adenine nucleotide translocator protein (Ant1). These mice exhibit histological,...
6013632 Compounds and their combinations for the treatment of influenza infection  
Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or N-acetyl-L-cysteine, with or without antioxidants, is suitable for the treatment of influenza virus...
6012926 Virtual reality system for treating patients with anxiety disorders  
A virtual reality system provides effective exposure treatment for psychiatric patients suffering from a particular anxiety disorder. The system is characterized by a video screen disposed in front...
5998624 Haloisoquinoline carboxamide  
Compounds of the invention have the general structure ##STR1## X, Y or Z are, respectively independently, H, F or an isotope thereof, Br or an isotope thereof, I or an isotope thereof, At or an...
5990341 Diastereoselective synthesis hydroxyethylene dipeptide isosteres  
A process for the synthesis of hydroxyethylene dipeptide isosteres from α-N,N-di(protected)amino(alkyl or substituted alkyl) methyl ketones that can be efficiently carried out on an industrial ...
5990093 Treating HBV with phospholipid prodrugs of β-L-2',3'-dideoxyadenosine 5'-monophosphate  
A method for treating HBV infections comprising administering a 5'-phospholipid prodrug of β-L-2',3'-dideoxyadenosine 5'-monophosphate.
5986074 Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof  
The present invention relates to novel metal chelates, exemplified as technetium-99m or rhenium chelates, and to the process of preparing such metal chelates from corresponding ligands. These...
5985307 Device and method for non-occlusive localized drug delivery  
A device for the local delivery of a substance into a natural tissue conduit in the mammalian body. The device provides a means for locally delivering a substance into the boundary layer of fluid...
5981247 Recombinant hepatitis C virus RNA replicase  
A recombinant RNA-dependent RNA polymerase of hepatitis C virus (r-HCV-RDRP) coding DNA was cloned and expressed yielding active enzyme in vitro. The r-HCV-RDRP can include up to 20 added amino...
5976536 Neisseria mutants, lipooligosaccharides and immunogenic compositions  
Provided herein are mutant strains of Neisseria meningitidis which produce lipooligosaccharide (LOS) differing from the wild-type LOS in structure as well as the mutant LOS molecules and...
5969094 Anti-paramyxovirus screening method and vaccine  
A method is provided for detecting whether a test composition can inhibit cell fusion mediated by paramyxovirus infection. A method is also provided for identifying an antiviral peptide capable of...
5959014 Water-stabilized organosilane compounds and methods for using the same  
The product of reacting an organosilane optionally having a nonhydrolizable organic group, but having one or more hydrolyzable groups, with a polyol containing at least three hydroxy groups, where...
5955053 Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof  
The present invention relates to novel metal chelates, exemplified as technetium-99m or rhenium chelates, and to the process of preparing such metal chelates from corresponding ligands. These...
5939276 Flow cytometry assay for heparin-induced thrombocytopenia  
The present invention relates to a flow cytometry assay for the determination of heparin-induced thrombocytopenia. This method (a) detects in a plasma sample the presence of anti-heparin antibodies...
5932715 Nucleotide sequences encoding a CS2 pilin protein  
Provided herein is a nucleotide sequence encoding a CS2 pilin protein of enterotoxigenic Escherichia coli. Also provided herein are the nucleotide sequences of coding sequences linked to the CS2...
5925643 Enantiomerically pure β-D-dioxolane-nucleosides  
A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure β-D-dioxolanyl purine nucleoside of ...
5919797 Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites  
Halogenated naphthyl methoxy piperidines having a strong affinity for the serotonin transporter are disclosed. Those compounds can be labeled with positron-emitting and/or gamma emitting halogen...
5919158 Method and apparatus for preventing and clearing condensation on the lens during a fluid-gas exchange portion of a pars plana vitrectomy  
An infusion cannula for use in clearing and preventing condensation on the posterior surface of an artificial lens during the fluid-gas exchange portion of a pars plana vitrectomy is described. The...
5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith  
The present invention provides a method for inhibiting an immune reponse and a method for inhibiting rejection of transplanted tissues. This method comprises preventing an endogenous molecule on a...
5914400 Method and compositions for the synthesis of BCH-189 and related compounds  
The present invention relates to a method of preparing BCH-189 and various analogs of BCH-189 from inexpensive precursors with the option of introducing functionality as needed. This synthetic...
5914331 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane  
A method and composition for the treatment of HIV and HBV infections in humans is disclosed that includes administering an effective amount of...
5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides  
A method and composition for the treatment of HIV and HBV infections in humans and other host animals is disclosed that includes the administration of an effective amount of a 5-carboxamido or...
5899882 Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient  
Apparatus and method are described for delivery of a treating element, such as a radiation source, through a catheter to a desired site in the intraluminal passageways of a patient, such as a...
5892025 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers  
A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that referentially catalyzes a reaction in one of the...
5888974 Hybrid human/animal factor VIII  
A hybrid procoagulant factor VIII is produced by isolation and recombination of human and other nonhuman mammalian factor VIII subunits or domains, or by genetic engineering of the human and animal...
5888475 Labeled cocaine analogs  
Novel methods for positron emission tomography or single photon emission spectroscopy using tracer compounds having the structure: ##STR1## where X in β configuration is phenyl, naphthyl; 2,3 or ...
5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases  
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of...
5872107 Treatment of urogenital cancer with boron neutron capture therapy  
Methods and compositions for treating urogenital tumors, and in particular, cancer of the prostate, bladder, and kidney, with BCNT, are disclosed. Any boron-containing compound that is sufficiently...
5865766 Multichannel, multipurpose sample collection and drug delivery system for laboratory animals  
A multichannel, multipurpose sample collection and drug delivery system for laboratory animals includes several sampling and/or infusion devices mounted on a powered turntable above the cage but...
5864038 Labeled cocaine analogs  
Novel compounds having the structure: ##STR1## where X in β configuration is phenyl, naphthyl; 2,3 or 4-iodophenyl; 2,3 or 4-(trimethylsilyl)phenyl; 3,4,5 or 6-iodonaphthyl; 3,4,5 or ...
5859204 Modified factor VIII  
Site-specific replacement of amino acids in the region of positions 484-509 of human factor VIII can result in reduction of reactivity to an inhibitory antibody while procoagulant activity is...
5852027 Antiviral 1,3-dioxolane nucleoside analogues  
This invention includes the compounds 2'-deoxy-5-fluoro-3'-oxacytidine, (-)-2'-deoxy-5-fluoro-3'-oxacytidine, and (+)-2'-deoxy-5-fluoro-3+-oxacytidine, and pharmaceutically acceptable salts thereof...
5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases  
A method for the treatment of cardiovascular diseases and noncardiovascular inflammatory diseases that are mediated by VCAM-1 is provided that includes the removal, decrease in the concentration...
5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity  
A method and composition for the treatment of humans infected with HBV that includes the administration of an HBV treatment amount of a β-dioxolanyl purine nucleoside of the formula: ##STR1## ...
5832878 Apparatus permitting tethered laboratory animals to move freely  
A multichannel, multipurpose sample collection and drug delivery system for freely-moving laboratory animals includes several sampling and/or infusion devices mounted on a powered turntable above...